Srinivasan Anand, Lee Grace C, Torres Nelson S, Hernandez Kevin, Dallas Steven D, Lopez-Ribot Jose, Frei Christopher R, Ramasubramanian Anand K
Department of Biomedical Engineering, The University of Texas at San Antonio, San Antonio, TX, 78249, United States.
BioBridge Global LLC, San Antonio, TX, 78201, United States.
Biotechnol Rep (Amst). 2017 Nov 8;16:44-47. doi: 10.1016/j.btre.2017.10.004. eCollection 2017 Dec.
We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip for culturing community acquired methicillin resistant (CA-MRSA), and perform AST against clinical isolates of CA-MRSA. The chip platform holds promise for an impact in microbial biotechnology as an attractive high-throughput, lower sample volume and quicker alternative to conventional AST such as the traditional broth microdilution or the newer automated systems.
我们描述了一种用于抗菌药物敏感性测试(AST)的新型高通量纳米级微阵列平台的开发。该平台能够在单个芯片上以50纳升的体积处理480个样本,通过简单的浸入和冲洗步骤进行荧光读数分析,并且能够同时处理多个样本和芯片。我们展示了该芯片用于培养社区获得性耐甲氧西林金黄色葡萄球菌(CA-MRSA)的适用性,并对CA-MRSA的临床分离株进行了AST。作为一种有吸引力的高通量、低样本量且比传统AST(如传统肉汤微量稀释法或更新的自动化系统)更快的替代方法,该芯片平台有望对微生物生物技术产生影响。